Boehringer Ingelheim

Pharma

Boehringer-SBP, Fresenius-WuXi Bio, Evommune—Fierce Pharma Asia

BI formed a $7.4 billion tie-up with SBP. Fresenius collaborates with WuXi Bio in sweeping biosimilars deal. Evommune got a molecular glue from China.

Angus Liu Nov 6, 2026 8:04am

Boehringer drives liver health education at NASCAR races

Nov 5, 2026 10:54am

pay deal hand over cash licensing transaction money

Boehringer Ingelheim divests biologics CDMO unit in China

Sep 24, 2026 11:38am

European pharmas sound alarm over lagging innovation

Sep 22, 2026 11:29am

Boehringer again rises up rare disease reputation rankings

Aug 20, 2026 4:29am

Of biopharma's top 25 companies, 9 had double-digit sales bumps

Aug 12, 2026 11:47am